Home
CRSP
CRSP News

Latest CRISPR Therapeutics AG (CRSP) News on May 10, 2025

CRISPR Therapeutics (NasdaqGM:CRSP) Q1 2025 Revenue Increases 71% to US$1 Million

Simply Wall St.

a day ago

CRISPR Therapeutics (NasdaqGM:CRSP) Q1 2025 Revenue Increases 71% to US$1 Million

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

2 days ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet

Zacks

2 days ago

Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet

CRISPR Therapeutics First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

2 days ago

CRISPR Therapeutics First Quarter 2025 Earnings: Misses Expectations

CRISPR Therapeutics Q1 Earnings and Sales Miss Estimates, Stock Tanks

Zacks

3 days ago

CRISPR Therapeutics Q1 Earnings and Sales Miss Estimates, Stock Tanks

We're Not Very Worried About CRISPR Therapeutics' (NASDAQ:CRSP) Cash Burn Rate

Simply Wall St.

3 days ago

We're Not Very Worried About CRISPR Therapeutics' (NASDAQ:CRSP) Cash Burn Rate

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

Zacks

3 days ago

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

GlobeNewswire

3 days ago

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?

Zacks

5 days ago

Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

Zacks

7 days ago

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

8 days ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

2 Beaten-Down Stocks With Incredible Upside Potential

Motley Fool

10 days ago

2 Beaten-Down Stocks With Incredible Upside Potential

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

Zacks

15 days ago

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

Zacks

15 days ago

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

Morningstar Research

15 days ago

Analyst Report: CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks

16 days ago

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know

‘Incoming Regulatory Tailwinds’ to Spur 90% Upside for CRISPR Therapeutics Stock, Says BMO Capital

TipRanks

17 days ago

‘Incoming Regulatory Tailwinds’ to Spur 90% Upside for CRISPR Therapeutics Stock, Says BMO Capital

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

19 days ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

22 days ago

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

MT Newswires

23 days ago

BofA Adjusts Price Target on CRISPR Therapeutics to $80 From $86, Keeps Buy Rating

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week

Simply Wall St.

23 days ago

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week

3 Magnificent Stocks That Could Double or More by 2030

Motley Fool

a month ago

3 Magnificent Stocks That Could Double or More by 2030

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Motley Fool

a month ago

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

CRISPR Therapeutics AG (CRSP) Stock Moves -1.81%: What You Should Know

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Stock Moves -1.81%: What You Should Know

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

Motley Fool

a month ago

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

a month ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation

Simply Wall St.

a month ago

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation

CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

Motley Fool

a month ago

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

a month ago

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

MT Newswires

a month ago

RBC Cuts Price Target on CRISPR Therapeutics to $38 From $48, Keeps Sector Perform, Speculative Risk

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks

a month ago

Biotech stocks slide as Marks resignation seen being negative for sector

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

Investor's Business Daily

a month ago

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Motley Fool

a month ago

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Intellia Focuses on Pipeline Development Amid Stiff Competition

Zacks

a month ago

Intellia Focuses on Pipeline Development Amid Stiff Competition

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

Investor's Business Daily

a month ago

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics

Zacks

a month ago

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Zacks

a month ago

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Novo gains Lexicon obesity drug; CRISPR COO to step down

BioPharma Dive

a month ago

Novo gains Lexicon obesity drug; CRISPR COO to step down

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline

Simply Wall St.

a month ago

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline

MT Newswires

a month ago

CRISPR Therapeutics COO to Step Down

CRISPR Therapeutics Announces Transition of Chief Operating Officer

GlobeNewswire

a month ago

CRISPR Therapeutics Announces Transition of Chief Operating Officer

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year

Simply Wall St.

a month ago

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts

Insider Monkey

a month ago

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

2 Beaten-Down Stocks to Buy on the Dip

Motley Fool

2 months ago

2 Beaten-Down Stocks to Buy on the Dip

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

Investor's Business Daily

2 months ago

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

2 No-Brainer Biotech Stocks to Buy Right Now

Motley Fool

2 months ago

2 No-Brainer Biotech Stocks to Buy Right Now

Is CRISPR Therapeutics (CRSP) One of the Most Shorted Stocks in 2025?

Insider Monkey

2 months ago

Is CRISPR Therapeutics (CRSP) One of the Most Shorted Stocks in 2025?

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?

Zacks

2 months ago

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

Insider Monkey

2 months ago

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

CRISPR Therapeutics (CRSP): Among Top Stocks to Buy from Ark Invest’s Portfolio

Insider Monkey

2 months ago

CRISPR Therapeutics (CRSP): Among Top Stocks to Buy from Ark Invest’s Portfolio

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?

Zacks

2 months ago

Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?

ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics

Pharmaceutical Technology

2 months ago

ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics

Shareholders in CRISPR Therapeutics (NASDAQ:CRSP) are in the red if they invested a year ago

Simply Wall St.

2 months ago

Shareholders in CRISPR Therapeutics (NASDAQ:CRSP) are in the red if they invested a year ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 03/03/2025

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Motley Fool

2 months ago

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire

2 months ago

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street

Motley Fool

3 months ago

2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street

CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts

Insider Monkey

3 months ago

CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts

CRISPR Therapeutics AG (CRSP): Among the Most Oversold Healthcare Stocks to Buy Now

Insider Monkey

3 months ago

CRISPR Therapeutics AG (CRSP): Among the Most Oversold Healthcare Stocks to Buy Now

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Zacks

3 months ago

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Investing.com

3 months ago

Street Calls of the Week

Why CRISPR Therapeutics (CRSP) Soared on Friday?

Insider Monkey

3 months ago

Why CRISPR Therapeutics (CRSP) Soared on Friday?

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

GuruFocus.com

3 months ago

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

CRISPR Therapeutics Stock Upgrade Following Analyst Reassessment

GuruFocus.com

3 months ago

CRISPR Therapeutics Stock Upgrade Following Analyst Reassessment

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

Motley Fool

3 months ago

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

Morningstar Research

3 months ago

Analyst Report: CRISPR Therapeutics AG

Crispr Therapeutics price target raised to $86 from $85 at BofA

TipRanks

3 months ago

Crispr Therapeutics price target raised to $86 from $85 at BofA

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

Zacks

3 months ago

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

MT Newswires

3 months ago

Truist Securities Adjusts Price Target on CRISPR Therapeutics to $120 From $100, Keeps Buy Rating

MT Newswires

3 months ago

TD Cowen Upgrades CRISPR Therapeutics to Hold From Sell, Adjusts Price Target to $35 From $30

MT Newswires

3 months ago

RBC Lowers Price Target on CRISPR Therapeutics to $48 From $53, Keeps Sector Perform, Speculative Risk

MT Newswires

3 months ago

CRISPR Therapeutics Swings to Q4 Loss, Revenue Falls

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

3 months ago

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

MT Newswires

3 months ago

BofA Securities Adjusts CRISPR Therapeutics Price Target to $86 From $85, Maintains Buy Rating

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

Motley Fool

3 months ago

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

CRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

Zacks

3 months ago

CRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

CRISPR Therapeutics AG (CRSP): Among Cathie Wood’s Top Stock Picks for 2025

Insider Monkey

3 months ago

CRISPR Therapeutics AG (CRSP): Among Cathie Wood’s Top Stock Picks for 2025

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Zacks

3 months ago

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today

Zacks

3 months ago

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today

Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?

Zacks

3 months ago

Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?

MT Newswires

3 months ago

HC Wainwright Initiates CRISPR Therapeutics at Buy With $65 Price Target

Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why

Insider Monkey

3 months ago

Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

CRISPR Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference

GlobeNewswire

3 months ago

CRISPR Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?

Zacks

4 months ago

CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?

My Top 5 Stocks to Buy in Early 2025

Motley Fool

4 months ago

My Top 5 Stocks to Buy in Early 2025

CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential

Insider Monkey

4 months ago

CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential

CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?

Zacks

4 months ago

CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

Motley Fool

4 months ago

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

Share on Social Networks: